Work

Supplementary Table S2: Clinical trials of ribociclib from Ribociclib (LEE011): Mechanism of Action and Clinical Impact of This Selective Cyclin-Dependent Kinase 4/6 Inhibitor in Various Solid Tumors

Year: 2023

Type: supplementary-materials

Abstract: Ongoing and planned clinical trials of ribociclib.

DOI: 10.1158/1078-0432.22461978.v1

Authors: Debu Tripathy, Aditya Bardia, William R. Sellers

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361920356

Cites:

Cited by:

Related to: 10